(Q82065569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

1 reference

1 reference

Yuri Takeda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Shinichiro Shinzaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Kumiko Okudo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Kenta Moriwaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Kohei Murata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Eiji Miyoshi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

17 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

3036-3043

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

Biological function of fucosylation in cancer biology

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

MicroRNAs as biomarkers in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer--too good to be true?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Serum Markers of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Fucosylation and gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26490

7 January 2021

Identifiers

DOI

10.1002/CNCR.26490

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22006099%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference